<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04676074</url>
  </required_header>
  <id_info>
    <org_study_id>Rana Hesham</org_study_id>
    <nct_id>NCT04676074</nct_id>
  </id_info>
  <brief_title>Effect of Upper Limb Ergometer on the AIP in Post Menopausal Obese Women.</brief_title>
  <official_title>Effect of Upper Limb Ergometer on the Arthrogenic Index of Plasma in Post Menopausal Obese Women.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants had randomly divided into two equal groups. Group (A) which is the control group&#xD;
      receive normal routine medication. Group (B) will receive normal routine medication with the&#xD;
      treatment program of moderate intensity upper limb ergometer for 15 minute with frequency&#xD;
      three times per week for four weeks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Control group (A):&#xD;
&#xD;
        1. Each participant will sign a consent form after receiving a detailed explanation about&#xD;
           the procedure.&#xD;
&#xD;
        2. A blood sample will been taken by a nurse in a heparinized tube and delivered to lab&#xD;
           within six hours.&#xD;
&#xD;
        3. BMI will been measured body weight(Kg) and height (m2)&#xD;
&#xD;
           a. BMI= body weight (Kg)/ height (m2).&#xD;
&#xD;
        4. Waist circumference will be measured.&#xD;
&#xD;
        5. After one month blood analysis evaluation will be done to record the response to the&#xD;
           routine medication.&#xD;
&#xD;
      Training Procedure for group (B):&#xD;
&#xD;
        1. Each participant will sign a consent form after receiving a detailed explanation about&#xD;
           the procedure.&#xD;
&#xD;
        2. A blood sample will been taken by a nurse in a heparinized tube and delivered to lab&#xD;
           within six hours.&#xD;
&#xD;
        3. BMI will been measured body weight(Kg) and height (m2)&#xD;
&#xD;
           a. BMI= body weight (Kg)/ height (m2).&#xD;
&#xD;
        4. Waist circumference will be measured.&#xD;
&#xD;
        5. The maximum heart rate will be determined from Tanaka formula (208- 0.7 *age of the&#xD;
           participant)&#xD;
&#xD;
             -  Then the exercise load will be determined according heart rate reserve of the&#xD;
                participants ( maximum heart rate - resting heart rate).&#xD;
&#xD;
        6. Start with sitting resting without any effort for 5 min then Start at a low speed and&#xD;
           intensity for 5 minutes to warm up the body.&#xD;
&#xD;
        7. Increase the speed and intensity for 10-30 seconds before dropping it back for 2-5&#xD;
           minutes and Repeat according to the intensity.&#xD;
&#xD;
        8. Finally, a five minutes of cooling down with no resistance had performed.&#xD;
&#xD;
        9. After one month blood analysis evaluation will be done to record the response to the&#xD;
           routine medication.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 15, 2020</start_date>
  <completion_date type="Actual">March 31, 2021</completion_date>
  <primary_completion_date type="Actual">February 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants had randomly divided into two equal groups. Group (A) which is the control group receive normal routine medication. Group (B) will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participant</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of the upper body ergometer on arthrogenic index ( triglyceride/ high density lipoprotein)</measure>
    <time_frame>after one month of the trial application</time_frame>
    <description>Effect of the upper body ergometer on arthrogenic index ( triglyceride/ high density lipoprotein)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of the upper body ergometer on total body weight kg.</measure>
    <time_frame>after one month of the trial application</time_frame>
    <description>Effect of the upper body ergometer on total body weight kg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of the upper body ergometer on estimated maximum heart rate(beat/min).</measure>
    <time_frame>after one month of the trial application</time_frame>
    <description>Effect of the upper body ergometer on estimated maximum heart rate(beat/min).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Post Menopausal Obese Women</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>the participant will not do any exercise program but just they will take the routine medication.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electronic Upper limb( body) ergometer</intervention_name>
    <description>Electronic pedal for the upper limb using for training the upper body. Intensity, speed and resistance can be adjusted.</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  female aged 45-60 years old.&#xD;
&#xD;
          -  class 1 and 2 obesity.&#xD;
&#xD;
          -  post menopausal.&#xD;
&#xD;
          -  diagnosed as controlled diabetic.&#xD;
&#xD;
          -  diagnosed as controlled hypertensive.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  uncontrolled diabetic.&#xD;
&#xD;
          -  uncontrolled hypertensive.&#xD;
&#xD;
          -  class 3 and morbid obesity.&#xD;
&#xD;
          -  mentally unstable person.&#xD;
&#xD;
          -  Any shoulder, hand and elbow orthopedic or neural disorders.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Post Menopausal Obese Women</gender_description>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rana H El Banna, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of physical therapy at Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Outpatient clinic faculty of physical therapy at Cairo University</name>
      <address>
        <city>Giza</city>
        <zip>12613</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2020</study_first_posted>
  <last_update_submitted>June 6, 2021</last_update_submitted>
  <last_update_submitted_qc>June 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Rana Elbanna</investigator_full_name>
    <investigator_title>lecturer at faculty of physical therapy at Cairo University</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

